We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARR'S TENTATIVE METFORMIN ER APPROVAL PULLED
BARR'S TENTATIVE METFORMIN ER APPROVAL PULLED
January 13, 2004
Barr Pharmaceuticals’ tentative approval for a generic version of Bristol-Myers Squibb’s diabetes drug Glucophage XR has been withdrawn by the FDA because of concerns over the pharmaceutical ingredients used to make the product, the firm said Jan. 9.